IO Insights

View in Browser November 20, 2025 Advertisement NEWS FROM SIO Register Here to Secure Your Spot Elevate your expertise in Savannah, Georgia, USA, 4–8 February, at the SIO 2026 Annual Scientific Meeting. Experience bold science, innovative education, and hands-on training that will elevate your practice and expand the future of interventional oncology. Register Today Advertisement Submit Your Late Breaking Abstract! SIO is now accepting late breaking abstract submissions for the SIO 2026 Annual Scientific Meeting in Savannah, Georgia, USA. If your research was not ready for the original October deadline, you can still share new data and emerging results with the interventional oncology community. Submit by Friday, 2 January, and review the full guidelines on the Abstracts page. Expanded y90 Dosimetry Hands-on Workshop Elevate your expertise with four hours of immersive y90 dosimetry training with leading experts at the SIO 2026 Annual Scientific Meeting. The expanded y90 Dosimetry Hands-on Workshop, , held on Friday, 6 February, is designed to sharpen your skills and expand your confidence in radiation dosimetry. To register, add the y90 Dosimetry Hands-on Workshop to your SIO 2026 Annual Scientific Meeting registration during the checkout process. An additional fee is required to register for this workshop. Limited seats are available. For more information, a breakdown of lecture topics, and to view the expert faculty leading each session, please visit our website. Advertisement OPuS One Clinical Study News Promoted by Medtronic Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Learn More New in 2026: Palliative Pain in Cancer Patients Master Class Separate Registration Required Discover new ways to care for patients in pain during this immersive half-day program on Wednesday, 4 February, held in conjunction with the SIO 2026 Annual Scientific Meeting. Learn from global leaders in interventional oncology as you explore real cases, advanced techniques, and hands-on training designed to strengthen your clinical skills and elevate your practice. Learn More The RISE Forum Separate Registration Required Be part of the RISE Forum: Research, Innovation & Science Exchange on Wednesday, 4 February in Savannah. SIO is also offering the brand-new RISE Forum Scholarship, open to students, trainees, and early-career researchers passionate about IO. Selected recipients will be invited by 20 October 2025. The application period is now closed. Reserve your spot, and join a community committed to improving cancer pain management. Learn More Register for Our Upcoming Webinars Evidence to Impact Roundtable: Treating Large HCC Tumors with TheraSphere™ Y-90 Glass Microspheres Wednesday, 10 December | 7:00 - 8:00 p.m. ET Register Now Webinar Series Sponsored By: Did you miss any of our November webinars? You're in luck — you can catch them all on demand. Visit our webinar library to watch anytime. Browse On-Demand Webinars Secure Your Member Benefits for 2026 Renew your SIO membership and continue building momentum in your interventional oncology career. Stay connected to exclusive education, timely insights, and a strong professional community that supports your growth. Renew by 31 December 2025 to keep your benefits active for 2026. Renew Now Not an SIO member? Demonstrate your commitment to the IO field and to moving your own career forward by joining today! As an SIO member, you'll benefit immediately from the latest education and research, event discounts, exclusive opportunities to earn CME credit, and more. Listen To SIO's New Podcast Series Have you tuned in yet? Meet the Data: Conversations with Leading Experts on the Role of HCC and Immunotherapy brings expert insights on pivotal HCC immunotherapy trials straight to you, highlighting evolving evidence and its impact on clinical decision-making. To stream the full four-episode series and stay current on advances in HCC care, search for the "Society of Interventional Oncology Podcast" in your favorite podcast app. Listen on Spotify Listen on Apple Build Protocols. Get Funded. Lead Research. Applications are now open to participate in the first-ever Interventional Oncology Clinical Trials Methodology Workshop, a new initiative of SIO's Clinical Trial Collaborative. Held in a small-group setting at the University of Pennsylvania, this immersive five-day workshop — 19-23 May 2026 — combines expert-led sessions, protocol development groups, and one-on-one mentorship to foster collaboration and address the unique challenges of interventional oncology research. Designed for interventional oncologists and clinical researchers, the workshop equips participants with the skills to effectively design, write, and execute clinical trials. Learn More and Apply About the Workshop This workshop offers a deep dive into clinical trial design across all phases, with insights into regulatory frameworks, statistical principles, and cutting-edge methodologies like AI integration, cost-effectiveness analysis, and pragmatic trials. Participants will also explore how to incorporate biomarkers, imaging, and real-world data, while learning strategies for multi-center collaboration and securing funding. Expert faculty will lead one-on-one mentoring and small-group discussions, supporting participants as they finalize their trial protocol through the five-day workshop. Attend on Scholarship Seats are limited for this unique educational experience! Invited participants will receive: Complimentary registration Complimentary five-night stay at The Study at University City $750 travel stipend Apply For Scholarship INDUSTRY NEWS Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma Liver International via Wiley Online Library Transarterial chemoembolization is the standard locoregional therapy for unresectable hepatocellular carcinoma, but it has limitations due to high recurrence rates and hepatic toxicity. Low-molecular-weight fucoidan, derived from brown seaweed, exhibits anticancer and hepatoprotective properties. Read More A Study On the Safety and Effectiveness of Transcatheter Arterial Chemoembolization and Bevacizumab Arterial Infusion Combined As a Comprehensive Treatment for Hepatocellular Carcinoma Annals of Hepatology via ScienceDirect This study evaluates the safety and efficacy of combining transcatheter arterial chemoembolization with intra-arterial bevacizumab infusion in patients with advanced hepatocellular carcinoma. Read More IO Insights The Society of Interventional Oncology 2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA 202-367-1164 | Contact Us www.sio-central.org Mykaila Potts Content Editor, Multiview 972-910-6876 | Contact me Unsubscribe | Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE | SUBSCRIBE | PAST ISSUES Published by